ANNUAL REPORT 2021
A Letter from the President & CEO Elise W. Huszar, MBA
As I reflect on my 25 years of leadership at Geneva, I am humbled and energized to be at this place in time. It is astounding how much our organization has accomplished, not only in terms of fiscal performance, but also in our steadfast dedication to our military collaborators, research teams, and key stakeholders. Despite ongoing challenges in the world, we have not slowed down.
This year, thanks to the hard work of our employees, Geneva has ensured the optimal health and performance of service members and the communities they serve. As we navigated the impacts of the pandemic, we saw once again just how essential military medicine is.
The Future of Military Medicine. Today.
Timeline of Events
JAN
Geneva is awarded a subcontract for an expansion of the NCAA-DoD Concussion Assessment, Research, and Education (CARE) Consortium - the largest study in history of concussion and repetitive head injuries.
Read more
FEB
Geneva adds four new members to its Scientific Advisory Board (SAB) which provides scientific consult, advisement, and direction to Geneva’s senior leadership, program directors, principal investigators, and research administrators.
Read More
FEB
Neil Vining, MD, MBA is appointed Chair of the Board of Directors and seven new members join the Board of Directors.
Read More
MAR
Geneva accepts a grant from the National Institute of Allergy and Infectious Diseases (NIAID) on behalf of Yoann Stephane Le Breton, PhD for therapeutic phages research using synthetic biology - NIAID’s first series of grants focused exclusively on this therapy.
Read More
APR
The 4D Bio3 program is elevated to a Center for Biotechnology by the Uniformed Services University.
Read More
APR
Don Goss, DPT, PhD, ATCH ties for second place in podium presentations for original research at the Womack Army Research Symposium for ‘Physical Therapy Sick Call Improves Soldier Readiness.’
Read More
MAY
Geneva partners with the National Cancer Institute and the Army on two investigational grants for breast cancer research using novel antibody-drug conjugates.
Read More
JUN
Geneva is selected to support a monoclonal antibody protocol under the NIH-Sponsored ACTIV-2 partnership at two military treatment facilities to advance treatments for COVID-19.
Read More
JUN
Funding for the TriService Nursing Research Program (TSNRP) is restored by Congress. Geneva serves as TSNRP's program management office.
Read More
JUN
LTC Christopher Stucky, PhD, RN, wins Best Research Poster for his research on medical communication errors in hospitals at the Naval Medical Center Camp Lejeune Research Symposium. PI MAJ Melissa Miller, PhD wins Best Podium Presentation for her research on retaining a military nursing workforce.
Read More
JUL
LTC Christopher Colombo, MD wins the BG George J. Brown Mentor’s Cube Award. Former Geneva PI COL (Ret) Edward Arrington, MD wins Best Clinical Session and the COL Paul J. Amoroso Staff Award at Madigan Army Medical Center Research Day.
Read More
AUG
Geneva is a founding member of the North Carolina Center for Optimizing Military Performance (NC-COMP) consortium which brings together more than 90 partners to provide human performance solutions for the military.
Read More
SEP
Geneva is awarded a GSA Schedule under the Multiple Award Schedule (MAS) from the General Services Administration (GSA) to further advance military medical research.
Read More
OCT
An unexpected finding by the University of Maryland, co-funded by Geneva, provides new insight into how the human body responds to malaria infection which may help to identify new ways to treat malaria..
Read More
OCT
A $2.1M award to address low-level blast effects of neurodegeneration on service members is awarded to Geneva on behalf of V. Sujith Sajja, PhD at Walter Reed Army Institute of Research.
Read More
NOV
Kenneth Cameron, PhD, MPH, ATC at Keller Army Community Hospital is awarded Geneva’s 2020 Researcher of the Year for his substantial impact in injury prevention, musculoskeletal injury and disease epidemiology, and associated treatment outcomes.
Read More
NOV
Geneva’s SAB awards Stacy Dolan, RN the 2021-2023 Jonas Nursing and Veterans Healthcare scholarship to advance veterans’ healthcare.
Read More
2021 by the numbers
Worldwide Impact
Global Presence
Award Revenue
($34.9M Received and Pending)
Research Programs
Top 15 Research Areas
by Funded Amount
14%
13%
10%
5%
4%
4%
4%
3%
3%
3%
3%
2%
2%
1%
Rehabilitative Medicine
Regenerative Medicine
Critical Care
Telemedicine
Neurology
Evidence Based Practice (EBP)
Oncology
Behavioral & Mental Health
Orthopedics
Federal Contract Services
Emergency Medicine
Pain Management
Pulmonology
Health Informatics
Performance Sites
Geneva’s global influence can be found at over 50 military treatment facilities and federal laboratories worldwide.
Focused Regional Impact
Geneva in the National Capital Region Geneva in San Antonio Geneva in North Carolina
David Grant Medical Center
Marine Corps Air Station Miramar Branch Health Clinic
Naval Health Research Center
Naval Hospital Camp Pendleton
Naval Hospital Twentynine Palms
Navy Medical Center San Diego
Evans Army Community Hospital
U.S. Air Force Academy Hospital
Navy Trauma Training Center
Centers for Disease Control and Prevention
Eisenhower Army Medical Center
Telemedicine and Advanced Technology Research Center – Mobile Health Innovation Center
Tripler Army Medical Center
Malcolm Grove Medical Center
Military Operational Medicine Research Program
National Cancer Institute
Naval Medical Research Center
Telemedicine and Advanced Technology Research Center
U.S. Army Medical Research and Development Command
U.S. Army Medical Research Institute of Chemical Defense
U.S. Army Medical Research Institute of Infectious Diseases
Uniformed Services University
Walter Reed Army Institute of Research
Walter Reed National Military Medical Center
Nellis Air Force Base
Keller Army Community Hospital
Naval Hospital Camp Lejeune
Womack Army Medical Center
Wright Patterson Air Force Base
Brooke Army Medical Center
Regional Health Command Central
U.S. Army Institute of Surgical Research
US Army Medical Center of Excellence
Wilford Hall Medical Center
William Beaumont Army Medical Center
Fort Belvoir Community Hospital
Naval Medical Center Portsmouth - VA
Madigan Army Medical Center
Federal Aviation Administration
Armed Forces Research Institute of Medical Sciences
Landstuhl Regional Army Medical Center
Accelerating Daring Discoveries
Researcher Accomplishments
Researcher of the Year
Kenneth Cameron, PhD, MPH, ATC has been named The Geneva Foundation’s 2020 Researcher of the Year.
Read more20 Researchers to Watch Series
Cristóbal S. Berry-Cabán
PhD
Dr. Cristóbal Berry-Cabán is studying an innovative approach at Womack Army Medical Center with the goal of preventing sexual aggression among young men in the military.
Read More
Kathleen Cashman
PhD
Dr. Kathleen Cashman, in collaboration with Inovio Pharmaceuticals, is working to translate a DNA-based vaccine candidate into, eventually, an FDA-approved vaccine to prevent lethal Lassa fever infection.
Read More
LTC Jonathan F. Dickens
MD, USA
LTC (Dr.) Jon Dickens is combining next-generation regenerative medicine techniques in tissue engineering and rehabilitative medicine to improve the long-term health of our warfighters.
Read More
COL Jennifer M. Gurney
MD, USA
COL (Dr.) Gurney is a trauma surgeon and Chief of the Defense Committees on Trauma at the Joint Trauma System working on the Deployed HEROES study.
Read More
COL (Ret.) Arthur “Don” Johnson
NC, PhD, USAF
Dr. Don Johnson was honored with the very first Annual Tri-Service Nursing Research Program Mentorship Award honoring his efforts as a nurse scientist mentor within the nursing research community.
Read More
Nicholas Ieronimakis
PhD
Dr. Nicholas Ieronimakis was awarded an investigational grant in reproductive medicine and maternal health from Ferring Pharmaceuticals to evaluate human placenta response to SARS-CoV-2 exposure.
Read More
Yoann Stephane Le Breton
PhD
Dr. Yoann Le Breton, research scientist at the Walter Reed Army Institute of Research, was awarded a grant for research focused on a platform for genome mining of multidrug-resistant pathogens to develop therapeutic phages using synthetic biology.
Read More
Rosa Nguyen
MD, PhD
Dr. Rosa Nguyen is a pediatric oncologist, translational researcher, and clinical scientist who first became interested neuroblastoma research during her clinical training while caring for children afflicted with this debilitating cancer.
Read More
Col. Jason F. Okulicz
MD, USAF
Col (Dr.) Jason Okulicz is an infectious diseases consultant to the Air Force Surgeon General who has enrolled 1,300+ patient participants in his work with Geneva to fight COVID-19.
Read More
Teryn R. Roberts
PhD
Dr. Teryn Roberts is a co-principal investigator for Geneva at the Autonomous Reanimation and Evacuation Program (AREVA) at Brooks City-Base.
Read More
MAJ (Ret) Dan Rhon
DPT, DSC, USA
Dr. Dan Rhon is the Director of the Primary Care Research Center at the Center for the Intrepid at Brooke Army Medical Center and is leading several translational research projects around pain management.
Read More
Venkatasivasai Sujith Sajja
PhD
Dr. Sujith Sajja has spent over the last decade investigating blast effects using state-of-the-art MRI technologies, pre-clinical models, and translational studies to understand and prevent risk against warfighters following blast trauma.
Read More
Amanda Staudt
PhD, MPH
Geneva Epidemiologist Dr. Amanda Staudt is working at the U.S. Army Institute of Surgical Research to conduct the first study of its kind to provide a representation of the actual number of years of healthy life lost to the ocular injury resulting from combat.
Read More
LTC Christopher Stucky
PhD, RN, CNOR, CSSM, NEA-BC, USA
LTC Christopher Stucky is a Nurse Scientist and Deputy Chief of Research at the Center for Nursing Science and Clinical Inquiry at Womack Army Medical Center.
Read More
Allison Symsack
PT, DPT
Geneva Senior Research Physical Therapist Dr. Allison Symsack is working on the Mobile Device Outcomes-based Rehabilitation Program, a DoD/VA Joint Incentive Fund, to determine if wearable sensor technology improves strength, mobility, and gait quality in service members and veterans with lower limb amputation.
Read More
Britton Trabert
PhD, MS
Dr. Britton Trabert is a reproductive and cancer epidemiologist. Under a research study titled Making the CASE: Chemopreventive use of Aspirin for Ovarian Cancer, her goal is to inform potential public health recommendations regarding aspirin as a chemopreventive agent for ovarian cancer.
Read More
MAJ Jon Umlauf DPT,
DSc, OCS, FAAOMPT, USA
MAJ (Dr.) Jon Umlauf is a physical therapist at Brooke Army Medical Center who is using cutting-edge, simulation-based treatments to return injured military service members to duty.
Read More
LTC Christopher VanFosson
PhD, MHA, RN, NEA-BC, USA
LTC (Dr.) Christopher VanFosson’s research goal is to prepare clinicians for their deployed mission on the future battlefield and to minimize preventable combat deaths.
Read More
LCDR J. Kent Werner
MD, PhD, USN
LCDR (Dr.) Kent Werner proposed the modification of a technology called functional Near-Infrared Spectroscopy, a non-invasive, portable optical brain monitoring technique to track fluid movements during sleep.
Read More
Ruoting Yang
PhD
Dr. Ruoting Yang first-authored a manuscript on biotypes for post-traumatic stress disorder, the first of their kind of any psychological disorder.
Read More
Improving Outcomes Through Collaboration
Program Accomplishments
Geneva’s unwavering commitment to medical research results in a significant and widespread impact across many research areas. Here are a few program highlights.
Tackling COVID-19
Geneva is conducting clinical trials under the NIH-Sponsored Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)-2 and ACTIV-4 clinical trials to speed the development of the most promising COVID-19 treatments and vaccines. Read more
The second phase of National Tele-Critical Care Network (NETCCN) for COVID-19 is awarded to a Geneva cohort. Read more
Geneva is awarded a follow-on study of service members who have been vaccinated to study the effectiveness of COVID-19 vaccines. Read more
Geneva researchers conduct a study of SARs-CoV-2 prevention behaviors in military healthcare settings. Read more
Advancing Biotechnology Innovation in the Military
The USU- 4D Bio3 program is elevated and designated as a USU Center for Biotechnology by the Uniformed Services University. Read more
Optimizing Human Performance
The Fort Bragg Research Institute (FBRI) and Geneva co-found the North Carolina Center for Optimizing Military Performance (NC-COMP) with 90+ partners. Read more
Leading Musculoskeletal Injury Care Research
The Musculoskeletal Injury Rehabilitation Research for Operational Readiness (MIRROR) advance MSI research for the DoD. Read more
Renewing Support for Nursing Research
TSNRP funding is restored by Congress which allows for the advancement of more than 500 grants totaling more than $100 million. Nursing research has resulted in changes to clinical practice, education, and policy across the Defense Health Agency. Read more
At the heart of geneva
Our People
Geneva’s Wave the Flag award is presented quarterly to an exemplary employee who exceeds expectations and exhibits our core values - innovation, quality, superior customer service, integrity, teamwork, and respect for all.
With your support
Donor Impact
Geneva donors help to advance critical medical research that directly impacts military communities and the global public. Geneva’s Discovery Fund allows for unrestricted donor contributions to be distributed to pressing medical research in real-time. This past year, our donors addressed the demands for COVID-19 research and infectious diseases, trauma care, nutrition, biotechnology, and rehabilitative medicine.
Philanthropy Support of Precision Nutrition Research and its Impact on COVID-19
Research Insights with Dr. Mary McCarthy
Read more
Sponsors & Collaborators
We are grateful to our sponsors and collaborators for their support.
AbCellera Biologics Inc.
ABBS Solutions
Acerta Pharma
Advanced Technology International
Advanced Bioprocess Systems
Albert Einstein College of Medicine
Allergan PLC
Alira Health
Altor Bioscience Corporation
Amgen
Applied Research Associates
Arena Pharmaceuticals
Army Nurse Corps Association
AstraZeneca
Athens Orthopedic Clinic
BeiGene USA
BioCryst Pharmaceuticals
Biomojo
Bristol-Myers Squibb Co.
Celdara Medical
Celgene Corporation
Centers for Disease Control and Prevention
CEPI
Children’s Hospital of Philadelphia
Children's Oncology Group
Cofactor Genomics
Conatus Pharmaceuticals
Congressionally Directed Medical Research Programs
Continuous Precision Medicine
Council of the Queensland Institute of Medical Research
CSL Behring
Cytosorb
Daiichi Sankyo
Defense Advanced Research Projects Agency
Defense Health Agency
Defense Threat Reduction Agency
Diomics Corporation
Deverra Therapeutics
DJO Global
DocBox
Duke University
Draeger
Draper
Echosens
Eli Lilly and Company
Emory University
Epicentrx
Evrys Bio
Exact Sciences
Exonicus, Inc
Ferring Pharmaceuticals
Food & Drug Administration
GALXOSMITHKLINE
Galera Therapeutics
GE Healthcare
Genfit Corporation
George Washington University
GeoVax
Gilead Sciences
H. Lee Moffitt Cancer Center and Research Institute
Halyard Health
Hamilton Health Sciences
Harvard University
Henry Jackson Foundation
HighTide Therapeutics USA
High Point University
Icon Clinical Research
Information Visualization and Innovative Research Inc. (IVIR)
Inovio Pharmaceuticals
Institute National de Recherche Biomedicale
Integrated Biotherapeutics
Intercept Pharmaceuticals
International Space Station U.S. National Laboratory
Irving Burton Associates
Janssen Therapeutics
Johns Hopkins University
Jonas Philanthropies
Kessler Foundation
Kura Oncology
Leidos Biomedical Research
Lutris Pharma
Madrigal Pharmaceuticals
Mapp BioPharmaceutical
Massachusetts General Hospital
Mayo Clinic
Medical Technology Enterprise Consortium
Medpace
Methodist Hospital, San Antonio
Microbiotix
Mimedx
Natick Contracting Division
National Cancer Institute
National Institute of Allergy and Infectious Diseases
National Institute of General Medical Sciences (Funder)
National Institutes of Health
New Jersey Regenerative Institute
New York School of Medicine
NGM Biopharmaceuticals
Navrogen
Nonin Medical Clinic
NorthSea
Novartis Pharmaceuticals
Novavax
Novo Nordisk
Novocure
Now Diagnostics
nScrypt
Oculogica
Olink
OMB Innovations
OmegicaQuant
Omnicure
Oregon Health & Science University
Parexel International Corporation
Pfizer
Pharm-Olam, LLC
Pharpoint Research
Phillips Healthcare
Prevent Biometrics
Purdue University
PRA Health Sciences
Regeneron Pharmaceuticals
Rhode Island Hospital
RoosterBio
RTI International
Rutgers University
SAB Biotheraputics
Safi Biosolutions
Sciperio
Society of Critical Care Medicine
Society for Simulation Healthcare
Seres
Spaulding Rehabilitation
Spectrum Pharmaceuticals
Stanford University
State University of New York - Stony Brook University
Society of Women in Urology
Symbient Product Development
Telemedicine & Advanced Technology Research Center
Texas A&M University
Texas Tech University Health Sciences Center
TG Therapeutics
Theradaptive
Thomas Jefferson University
Tobira Therapeutics
TriService Nursing Research Program
Tuskegee University
U.S. Army Institute for Chemical Defense
U.S. Army Medical Research Acquisition Activity
U.S. Army Medical Research and Development Command
U.S. Army Medical Research and Material Command
U.S. Army Medical Research Acquisition Activity
U.S. Army Medical Research Institute of Infectious Diseases
U.S. Army Research Lab - Orlando
U.S. Special Operations Command
Uniformed Services University
University of Akron
University of California
University of Georgia
University of Florida
University of the Incarnate Word
University of Iowa
University of Kentucky
University of Maryland – Baltimore County
University of Maryland – College Park
University of Miami
University of Minnesota
University of Missouri
University of Nebraska
University of New Mexico
University of North Carolina - Chapel Hill
University of Pittsburgh
University of San Francisco
University of South Alabama
University of South Florida
University of Texas, San Antonio
University of Utah
University of Virginia
University of Washington
Vanderbuilt University
Vapotherm
Veterans Administration
Virginia Commonwealth University
Vysnova Partners
Wayne State University
Western Michigan University
XBIOTECH USA
Xcovery Holdings
zCore Business Solutions
Zydus Pharmaceuticals
Top 5 Largest Awards
Geneva’s top five largest awards funded in 2021 totaled $ 26.8M.
Financials
Geneva continued to deliver strong performance in 2021.
|
Statement of Revenue & Expenditures |
2021 |
2020 |
2019 |
2018 |
|
(Rounded to the nearest thousand) |
|
|
|
|
|
Total Grant, Contract, and Other Award Revenue |
$79,606,529 |
$67,110,553 |
$55,938,475 |
$51,791,217 |
|
Grant |
$42,845,144 |
$46,734,995 |
$31,636,422 |
$26,976,833 |
|
Contract |
$33,989,179 |
$18,568,628 |
$21,899,095 |
$21,992,580 |
|
Other Award Revenue |
$2,772,206 |
$1,806,930 |
$2,402,958 |
$2,821,804 |
|
|
|
|
|
|
|
Program Expenses |
$69,833,205 |
$56,977,675 |
$47,892,929 |
$42,440,761 |
|
|
|
|
|
|
|
Net Income from Grants, Contracts, and Awards |
$9,773,324 |
$10,132,878 |
$8,045,546 |
$9,350,456 |
|
|
|
|
|
|
|
Support Services |
|
|
|
|
|
General and Administrative |
$8,612,976 |
$8,268,505 |
$8,240,252 |
$8,337,542 |
|
Fund Development |
$29,929 |
$73,830 |
$100,953 |
$99,346 |
|
Total Support Services |
$8,642,905 |
$8,342,335 |
$8,341,205 |
$8,436,888 |
|
|
|
|
|
|
|
Total Other Income (Loss) |
$85,111 |
$79,675 |
$78,342 |
($54,297) |
|
|
|
|
|
|
|
Increase (decrease) in net assets |
$1,215,530 |
$1,870,218 |
($217,317) |
$859,271 |
|
|
|
|
|
|
|
Unrestricted Net Assets |
|
|
|
|
|
Beginning of Year |
$6,423,444 |
$4,553,226 |
$4,770,543 |
$3,911,272 |
|
End of Year |
$7,638,974 |
$6,423,444 |
$4,553,226 |
$4,770,543 |